Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases - Wikidata - wikimedia - TriplyDB

Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases

Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases

http://www.wikidata.org/entity/Q36666637

about

Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins.Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME Age-related changes in redox signaling and VSMC function.Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.Role of the endothelium in inflammatory bowel diseases.Angiotensin II modulates interleukin-1β-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-κB crosstalk Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure Endothelial γ-glutamyltransferase contributes to the vasorelaxant effect of S-nitrosoglutathione in rat aorta.Phytanic acid activates NADPH oxidase through transactivation of epidermal growth factor receptor in vascular smooth muscle cells.Interplay between calcium and reactive oxygen/nitrogen species: an essential paradigm for vascular smooth muscle signaling Hydrogen peroxide: a Jekyll and Hyde signalling molecule.Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes.Lipofundin-induced hyperlipidemia promotes oxidative stress and atherosclerotic lesions in new zealand white rabbits.Lipopolysaccharide induced vascular smooth muscle cells proliferation: A new potential therapeutic target for proliferative vascular diseases.Effects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells.Mechanism of Sirt1 NAD+-dependent Protein Deacetylase Inhibition by Cysteine S-Nitrosation.Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated γ-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease.

P2860

Q28577829-9C2CAD8D-F6EB-4BCB-ABB4-301B4D5D93BC Q33772560-1810D50E-F0EC-41DE-B557-AFD32339095B Q33816476-BBED6D7A-2067-4966-B5E4-A4898F9B394C Q33830145-F98631EA-44CE-491D-AFB7-80968FC902A5 Q33867587-36911581-D27A-4E9F-823B-473EB5BFEC59 Q34270071-AA55B281-EF75-4C60-9987-B1457A1A6487 Q34579746-F1DC6290-E290-470E-B55C-2E709950DD2A Q35116630-128F77F8-FD56-4874-9B50-6DF6CE63A138 Q35121079-9E72F4F1-924E-4AE0-B9AE-DD646EF1C1F8 Q36226859-7DB8E1D6-CD6D-498A-B5A2-D3F55DC761FB Q36994556-C9FCA5B6-210F-4AEB-8507-837C9F2C61CC Q37589624-B6C40E3C-F505-4899-BB5F-6B72BEB1DD29 Q37942731-2CD76374-DE08-49F2-9414-C43369AF74C2 Q38486377-B2B86FE7-C42F-4D41-BE41-129DDA2710E5 Q38603151-60D08771-59A7-4114-A79E-718F328DB556 Q39114943-C94AA0DD-8A57-4178-9B76-1259F8FE5CA8 Q40006665-D3BBB18C-5D16-4506-AB41-2F4B7BBBA7E9 Q46353864-AD00F4B5-B208-49D8-8BC3-8642E400C159 Q51304159-DBC0B527-9CC6-48C7-B9CF-279EA158A341

P2860

Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases

http://www.wikidata.org/entity/Q36666637

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Regulation of smooth muscle by ...... ascular proliferative diseases

@ast

Regulation of smooth muscle by ...... ascular proliferative diseases

@en

type

label

Regulation of smooth muscle by ...... ascular proliferative diseases

@ast

Regulation of smooth muscle by ...... ascular proliferative diseases

@en

prefLabel

Regulation of smooth muscle by ...... ascular proliferative diseases

@ast

Regulation of smooth muscle by ...... ascular proliferative diseases

@en

P1433

Q36666637-1E20F57A-9BBC-4FDC-A653-4F31A0E2B15B

P1476

Q36666637-37AF565D-711F-499A-BA25-9092AD66AB1F

P2093

Q36666637-13D17FDB-AF2F-4086-88F1-D5AEF3E557FA

Q36666637-31933C29-3F88-42ED-8756-71E29C8BAF21

Q36666637-71B91C35-8F40-4152-827B-D819D24671A5

Q36666637-8EEF48E5-CC45-41C2-B859-70D0B4F048B4

Q36666637-9B9A9372-2E6D-45D5-88FA-BD4F97294E18

P2860

Q36666637-00587D98-8E10-4AD5-9CEE-B1A6A7361981

Q36666637-0148E56B-11FE-4972-8553-136AD8A52FE9

Q36666637-04556EB3-BC61-4A3C-AED6-CD7F8E2CDFC9

Q36666637-04CDBC8E-B7FD-4957-9300-5B3037AEDBF4

Q36666637-074230C3-3191-44E9-952C-802F0952609C

Q36666637-092B6CCD-5568-47BB-A038-E2E903E496E1

Q36666637-099B9AF9-CDDA-4DE2-A228-37F3CCD9C170

Q36666637-09A2541B-CEC8-484D-9F03-464CD8C29FD7

Q36666637-0AF0887E-7FF0-4787-BEA9-A669604CCDF9

Q36666637-0CF35C28-4E6E-47DA-A0D0-574CA41A695D

P304

Q36666637-3EDE9370-AEC8-43FC-8316-580E0BA6FD37

P31

Q36666637-436BC164-BD58-4964-8C43-FCF9A15D25AD

P356

Q36666637-F12BF6CF-9979-4271-945B-138D38413E69

P433

Q36666637-65DA42FD-9ED4-431E-A14A-665832715D9E

P478

Q36666637-F63B5806-3D2C-4CEB-9BCE-3C1431385900

P577

Q36666637-5DF91333-3244-4F3C-A6EE-773682A0FE3D

P5875

Q36666637-416D6FD6-6E20-4AA0-84D1-D8023B5B67A0

P698

Q36666637-E4861F9E-A7E8-458C-91EC-97F84F3A1816

P932

Q36666637-F68E4226-5E8E-4792-A632-BF29C89DF4BB

P356

J.FREERADBIOMED.2007.12.025

P1433

Free Radical Biology and Medicine

P1476

Regulation of smooth muscle by ...... ascular proliferative diseases

@en

P2093

Benjamin J Guikema

http://www.w3.org/2001/XMLSchema#string

David Jourd'heuil

http://www.w3.org/2001/XMLSchema#string

Harold A Singer

http://www.w3.org/2001/XMLSchema#string

Katharine E Halligan

http://www.w3.org/2001/XMLSchema#string

Roman Ginnan

http://www.w3.org/2001/XMLSchema#string

P2860

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

Negative regulation of PYK2/related adhesion focal tyrosine kinase signal transduction by hematopoietic tyrosine phosphatase SHPTP1

A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes

Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant

Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases

Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes

Interaction between the SH3 domains and C-terminal proline-rich region in NADPH oxidase organizer 1 (Noxo1)

NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176

Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets

P304

1232-1245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FREERADBIOMED.2007.12.025

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5639562

http://www.w3.org/2001/XMLSchema#string

P698

18211830

http://www.w3.org/2001/XMLSchema#string

P932

2390910

http://www.w3.org/2001/XMLSchema#string